[go: up one dir, main page]

FI894045A7 - Menetelmä terapeuttisesti aktiivisen 10-atsaspiro-9-fluori-2,3-dihydro-3-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojohdannaisen valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisen 10-atsaspiro-9-fluori-2,3-dihydro-3-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojohdannaisen valmistamiseksi

Info

Publication number
FI894045A7
FI894045A7 FI894045A FI894045A FI894045A7 FI 894045 A7 FI894045 A7 FI 894045A7 FI 894045 A FI894045 A FI 894045A FI 894045 A FI894045 A FI 894045A FI 894045 A7 FI894045 A7 FI 894045A7
Authority
FI
Finland
Prior art keywords
azaspiro
benzoxazine
pyrido
dihydro
oxo
Prior art date
Application number
FI894045A
Other languages
English (en)
Swedish (sv)
Other versions
FI894045A0 (fi
FI92703B (fi
FI92703C (fi
Inventor
Isao Hayakawa
Shohgo Atarashi
Masazumi Imamura
Youichi Kimura
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of FI894045A0 publication Critical patent/FI894045A0/fi
Publication of FI894045A7 publication Critical patent/FI894045A7/fi
Priority to FI934016A priority Critical patent/FI101536B1/fi
Publication of FI92703B publication Critical patent/FI92703B/fi
Application granted granted Critical
Publication of FI92703C publication Critical patent/FI92703C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/54Spiro-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Dental Preparations (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI894045A 1988-08-31 1989-08-29 Menetelmä terapeuttisesti aktiivisen 10-atsaspiro-9-fluori-2,3-dihydro-3-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojohdannaisen valmistamiseksi FI92703C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI934016A FI101536B1 (fi) 1988-08-31 1993-09-14 Menetelmä terapeuttisesti käyttökelpoisten spirosubstituentin sisältävien kinoliini- tai naftyridiinikarboksyylihappojohdannaisten valmistamiseksi

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP21763888 1988-08-31
JP21763888 1988-08-31
JP23131888 1988-09-14
JP23131888 1988-09-14
JP29698588 1988-11-24
JP29698588 1988-11-24
JP15631689 1989-06-19
JP15631689 1989-06-19

Publications (4)

Publication Number Publication Date
FI894045A0 FI894045A0 (fi) 1989-08-29
FI894045A7 true FI894045A7 (fi) 1990-03-01
FI92703B FI92703B (fi) 1994-09-15
FI92703C FI92703C (fi) 1994-12-27

Family

ID=27473404

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894045A FI92703C (fi) 1988-08-31 1989-08-29 Menetelmä terapeuttisesti aktiivisen 10-atsaspiro-9-fluori-2,3-dihydro-3-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojohdannaisen valmistamiseksi

Country Status (20)

Country Link
US (1) US5508428A (fi)
EP (2) EP0357047B1 (fi)
KR (2) KR0148688B1 (fi)
CN (1) CN1036193C (fi)
AT (1) ATE160141T1 (fi)
AU (1) AU619891B2 (fi)
CA (1) CA1336090C (fi)
DE (2) DE68910441T2 (fi)
DK (1) DK174689B1 (fi)
ES (2) ES2111029T3 (fi)
FI (1) FI92703C (fi)
HK (1) HK1003000A1 (fi)
IE (2) IE63492B1 (fi)
IL (1) IL91474A (fi)
IN (1) IN170262B (fi)
MY (1) MY104652A (fi)
NO (1) NO177638C (fi)
NZ (1) NZ230484A (fi)
PH (1) PH31278A (fi)
PT (1) PT91602B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY109714A (en) * 1990-10-18 1997-04-30 Daiichi Seiyaku Co Process for preparing 8-chloroquinolone derivatives
US5137892A (en) * 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
EP0641339B1 (en) * 1991-06-19 1999-09-15 Pfizer Inc. Azaspiro quinolone antibacterial agents
US5276041A (en) * 1991-11-08 1994-01-04 Kaken Pharmaceutical Co., Ltd. Oxime derivatives
KR960011370B1 (ko) * 1991-12-31 1996-08-22 재단법인 한국화학연구소 스피로알킬아민 유도체와 그의 제조방법
EP0550016A1 (en) * 1991-12-31 1993-07-07 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and processes for preparing same
US5527910A (en) * 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
DK0688772T3 (da) * 1994-06-16 1999-11-01 Lg Chemical Ltd Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling
US5856518A (en) * 1995-05-26 1999-01-05 Daiichi Pharmaceutical Co., Ltd. Production process of cyclic compound
IL118815A (en) * 1995-07-13 2000-06-29 Anormed Inc N,N-diethyl-8,8-dipropyl-2-azaspiro¬4.5¾decane-2-propanamine dimaleate and pharmaceutical compositions comprising it
TW519542B (en) * 1996-09-27 2003-02-01 Daiichi Seiyaku Co Bicyclic amine derivative
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US20020032216A1 (en) * 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
KR100566346B1 (ko) 1997-06-26 2006-11-10 동화약품공업주식회사 퀴놀론카르복실산 유도체
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
DK1262477T3 (da) 2000-02-09 2008-12-01 Daiichi Sankyo Co Ltd Antibakterielle midler, der er virksomme mod syrefaste bakterier og indeholder pyridoncarboxylsyrer som aktiv ingrediens
WO2002014278A1 (en) * 2000-08-08 2002-02-21 Daiichi Pharmaceutical Co., Ltd. Processes for preparation of bicyclic compounds and intermediates therefor
JP4108311B2 (ja) * 2001-10-02 2008-06-25 ダイセル化学工業株式会社 1−アシル−1−シクロプロパンカルボン酸エステル誘導体の製造法
JP2003171354A (ja) * 2001-12-06 2003-06-20 Daicel Chem Ind Ltd 光学活性アミン化合物又はその塩の製造方法
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
US7563805B2 (en) 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
EP2249828A1 (en) * 2008-01-07 2010-11-17 Janssen Pharmaceutica, N.V. Preparation of sulfamide derivatives
EP2686320B1 (en) 2011-03-15 2016-05-18 Merck Sharp & Dohme Corp. Tricyclic gyrase inhibitors
WO2012150221A2 (de) 2011-05-04 2012-11-08 Bayer Cropscience Ag Neue halogenierte benzylalkoholester der cyclopropancarbonsäure als schädlingsbekämpfungsmittel
WO2012150208A1 (de) 2011-05-04 2012-11-08 Bayer Cropscience Ag Verwendung von substituierten benzylalkoholestern der cyclopropancarbonsäure zur bekämpfung von insektizid-resistenten insekten
CN103073481A (zh) * 2013-02-06 2013-05-01 上海药明康德新药开发有限公司 一种4-氮杂螺[2.4]庚烷盐酸盐的制备方法
US20200369611A1 (en) * 2017-08-01 2020-11-26 Boehringer Ingelheim International Gmbh Intermediate compounds and methods

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2814622A (en) * 1955-07-18 1957-11-26 Upjohn Co Organic compounds
GB984119A (en) * 1960-06-20 1965-02-24 Aspro Nicholas Ltd Substituted piperidines and methods for their preparation
US3418324A (en) * 1961-03-13 1968-12-24 Geschickter Fund Med Res Heterocyclic secondary amines
BE648317A (fi) * 1963-05-27
DE1961474A1 (de) * 1968-12-19 1970-07-02 Leuna Werke Veb Verfahren zur Herstellung von am Stickstoff unsubstituierten Oxaziridinen
US3859292A (en) * 1972-08-15 1975-01-07 Scm Corp N-haloacyl (2-spirocycloaliphatic) oxazolidines
US4011233A (en) * 1973-06-28 1977-03-08 Givaudan Corporation 2-methyl-2-(4-methyl-3-pentene-1-yl) thiazolidine
SE7713314L (sv) * 1976-12-17 1978-06-18 Rohm & Haas Artropodrepellenter
DD152706A5 (de) * 1980-08-21 1981-12-09 Stauffer Chemical Co Unkrautvertilgungsmittelzusammensetzung
US4777175A (en) * 1982-09-09 1988-10-11 Warner-Lambert Company Antibacterial agents
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
US4430335A (en) * 1983-02-09 1984-02-07 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1-azaspiro[4,5]decanes and their analgesic compositions
DE3322530A1 (de) * 1983-06-23 1985-01-10 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von mono-, bi- und tricyclischen aminosaeuren
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
DE3721745A1 (de) * 1986-07-04 1988-01-14 Lentia Gmbh Bicyclisch substituierte chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
ZA877471B (en) * 1986-10-08 1988-04-05 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acid antibacterial agents
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
IL90062A (en) * 1988-04-27 1994-10-07 Daiichi Seiyaku Co Pyridonecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤

Also Published As

Publication number Publication date
FI894045A0 (fi) 1989-08-29
IL91474A (en) 1994-05-30
US5508428A (en) 1996-04-16
NZ230484A (en) 1991-06-25
PT91602B (pt) 1995-05-31
MY104652A (en) 1994-05-31
AU4100689A (en) 1990-03-08
FI92703B (fi) 1994-09-15
CN1036193C (zh) 1997-10-22
PH31278A (en) 1998-07-06
KR900003152A (ko) 1990-03-23
DK426289A (da) 1990-03-01
ES2111029T3 (es) 1998-03-01
DE68928447D1 (de) 1997-12-18
AU619891B2 (en) 1992-02-06
NO177638B (no) 1995-07-17
IE930570L (en) 1990-02-28
IE82128B1 (en) 2002-02-20
KR0148719B1 (en) 1998-08-17
DK174689B1 (da) 2003-09-15
ES2061845T3 (es) 1994-12-16
CA1336090C (en) 1995-06-27
DE68910441D1 (de) 1993-12-09
IN170262B (fi) 1992-03-07
EP0357047A1 (en) 1990-03-07
DK426289D0 (da) 1989-08-30
IE63492B1 (en) 1995-05-03
DE68928447T2 (de) 1998-06-18
DE68910441T2 (de) 1994-03-03
EP0357047B1 (en) 1993-11-03
NO177638C (no) 1995-10-25
EP0529688B1 (en) 1997-11-12
IE892785L (en) 1990-02-28
EP0529688A2 (en) 1993-03-03
IL91474A0 (en) 1990-04-29
FI92703C (fi) 1994-12-27
NO893453D0 (no) 1989-08-29
PT91602A (pt) 1990-03-08
HK1003000A1 (en) 1998-09-30
KR0148688B1 (ko) 1998-08-17
EP0529688A3 (en) 1993-03-10
NO893453L (no) 1990-03-01
CN1100095A (zh) 1995-03-15
ATE160141T1 (de) 1997-11-15

Similar Documents

Publication Publication Date Title
FI894045A7 (fi) Menetelmä terapeuttisesti aktiivisen 10-atsaspiro-9-fluori-2,3-dihydro-3-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojohdannaisen valmistamiseksi
FI883050L (fi) Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
FI890652A7 (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI890282L (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI893794L (fi) Menetelmä valmistaa terapeuttisesti vaikuttavaa oksaspiro/2,5/oktaanijohdosta
FI862643A7 (fi) Menetelmä terapeuttisesti aktiivisen S(-)-9-halogeeni-3-alkyyli-10-(4-alkyylipiperatsinyyli)-7-okso-2,3-dihydro-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihapon valmistamiseksi
FI913446L (fi) Menetelmä valmistaa terapeuttisesti aktiivista 3-(2-substituoitu-3-okso-2,3-dihydropyridatsin-6-yyli)-2-fenyylipyratsolo/1,5-a/pyridiinejä
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
FI883249A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
DE3575924D1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro-7h-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure
FI892497L (fi) Menetelmä terapeuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi
FI893170L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 1,2,3-triatsolo/4,5-f/kinoksaliinijohdannaisten valmistamiseksi
FI891910A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyrido/1,2,3-de//1,4/bentsoksatsiinijohdannaisten valmistamiseksi
FI883603A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI873350A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI880869A7 (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
FI884471A7 (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI880467A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI890123L (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia indolyylipiperidiiniyhdisteitä
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
PT85778A (en) Process for protecting plants against diseases using isonicotinic acid derivatives
FI916058A7 (fi) Menetelmä terapeuttisesti aktiivisten dihydrobentsofuraanikarboksamidien valmistamiseksi
FI881104L (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
FI880190L (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia tetrahydrofuraanijohdoksia

Legal Events

Date Code Title Description
FG Patent granted

Owner name: DAIICHI PHARMACEUTICAL CO. LTD.

BB Publication of examined application
FG Patent granted

Owner name: DAIICHI PHARMACEUTICAL CO., LTD.